Research Topics
| Ulrike HaugSummaryAffiliation: University of Heidelberg Country: Germany Publications
| Collaborators
|
Detail Information
Publications
A simulation model for colorectal cancer screening: potential of stool tests with various performance characteristics compared with screening colonoscopyUlrike Haug
Department of Epidemiology, German Center for Research on Ageing, Bergheimer Strasse 20, Heidelberg 69115, Germany
Cancer Epidemiol Biomarkers Prev 14:422-8. 2005....- New stool tests for colorectal cancer screening: a systematic review focusing on performance characteristics and practicalnessUlrike Haug
Department of Epidemiology, German Centre for Research on Ageing, Heidelberg, Germany
Int J Cancer 117:169-76. 2005..g., the possibility of mailing the samples, is needed... - Sex differences in performance of fecal occult blood testingHermann Brenner
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Am J Gastroenterol 105:2457-64. 2010..We aimed to assess potential sex differences in performance of iFOBTs and gFOBT in the screening setting... - Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative testsUlrike Haug
German Cancer Research Center, Heidelberg, Germany
Am J Gastroenterol 105:682-90. 2010.... - Meta-analysis: Serum vitamin D and colorectal adenoma riskLu Yin
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Strasse 20, Heidelberg, Germany
Prev Med 53:10-6. 2011..To perform a systematic review and meta-analysis of human studies on the association between serum 25 hydroxyvitamin D (25(OH)D) and incident, sporadic colorectal adenoma (CRA) and CRA recurrence... - Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood testsHermann Brenner
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Int J Cancer 127:1643-9. 2010..Definition of cutoffs is a critical issue in the application of immunochromatographical tests and should be redefined for several of these tests... - Meta-analysis: serum vitamin D and breast cancer riskLu Yin
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Strasse 20, D 69115 Heidelberg, Germany
Eur J Cancer 46:2196-205. 2010..Further studies are needed to clarify the potential role and the relevant exposure time regarding vitamin D and breast cancer risk... - Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trendsChristian Stock
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Gastrointest Endosc 71:366-381.e2. 2010..We aimed to review prevalence estimates of history of colonoscopy or sigmoidoscopy in the general population and to analyze recent trends... - Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detectionSabrina Hundt
The German Cancer Research Center, Heidelberg, Germany
Ann Intern Med 150:162-9. 2009..Large-scale, colonoscopy-based screening studies that allow evaluation of these tests for the detection of precursor lesions are scarce... - Meta-analysis: Circulating vitamin D and ovarian cancer riskLu Yin
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Strasse 20, D 69115 Heidelberg, Germany
Gynecol Oncol 121:369-75. 2011..To review and summarize evidence from longitudinal studies on the association between circulating 25 hydroxyvitamin D (25(OH)D) and the risk of ovarian cancer (OC)... - Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancerMichael Hoffmeister
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Clin Gastroenterol Hepatol 8:870-6. 2010..Screening recommendations for colorectal cancer (CRC) commonly take family history but no other risk factors into account. We compared and assessed risk factors of colorectal polyps in a large population undergoing screening colonoscopy... - Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancerHeiko Muller
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
J Urol 180:1309-12; discussion 1312-3. 2008..In diagnostic studies promising results were shown for myeloid related protein-14 in serum and urine. However, confirmation in longitudinal population based studies is needed... - Sensitivity estimates of blood-based tests for colorectal cancer detection: impact of overrepresentation of advanced stage diseaseSha Tao
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Am J Gastroenterol 106:242-53. 2011..Adjustment of sensitivity to the stage distribution expected in the screening setting is crucial to obtain realistic and comparable estimates of sensitivities... - Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer riskLu Yin
German Cancer Research Center, Heidelberg, Germany
Cancer Epidemiol 33:435-45. 2009..To review and summarize evidence from longitudinal studies on the association between serum 25-hydroxyvitamin D (25(OH)D) and the risk of prostate cancer (PC)... - Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopyChristian Stock
German Cancer Research Center DKFZ, Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany
Gastrointest Endosc 73:435-443.e5. 2011..Use of colonoscopy is thought to reduce colorectal cancer (CRC) mortality, but its impact at the population level is unclear... - Subsite-specific colorectal cancer risk in the colorectal endoscopy eraChristian Stock
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Gastrointest Endosc 75:621-30. 2012..Colorectal endoscopy (sigmoidoscopy and colonoscopy) is thought to reduce colorectal cancer (CRC) risk. Since the 1980s, its use has increased in the United States, which may be a reason for decreasing CRC incidence rates... - Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adultsUlrike Haug
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Clin Chem 53:787-90. 2007..We investigated the prevalence and potential determinants of mutant K-ras in stool in a large sample of unselected older adults and assessed the association with colonoscopic findings... - Low-dose aspirin use and performance of immunochemical fecal occult blood testsHermann Brenner
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
JAMA 304:2513-20. 2010..Low-dose aspirin use, which increases the likelihood of gastrointestinal bleeding, is common in the target population for colorectal cancer screening... - Stool testing for the early detection of pancreatic cancer: rationale and current evidenceUlrike Haug
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center DKFZ, Bergheimer Street 20, Heidelberg 69115, Germany
Expert Rev Mol Diagn 8:753-9. 2008..Pertinent studies could greatly benefit from recent methodological advances gained in connection with stool testing for colorectal cancer... - Family history and age at initiation of colorectal cancer screeningHermann Brenner
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
Am J Gastroenterol 103:2326-31. 2008.... - Blood markers for early detection of colorectal cancer: a systematic reviewSabrina Hundt
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center DKFZ, Bergheimer Strasse 20, 69115 Heidelberg, Germany
Cancer Epidemiol Biomarkers Prev 16:1935-53. 2007..The purpose of this review was to give an overview of published studies on blood markers aimed at the early detection of CRC and to summarize their performance characteristics... - How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysisUlrike Haug
Division of Preventive Oncology, National Center for Tumor Diseases German Cancer Research Center DKFZ, Heidelberg, Germany
Int J Cancer 131:2094-102. 2012..Specifying an appropriate management strategy for individuals with a prior fpFOBT may substantially reduce required resources within a FOBT-based CRC screening program without limiting its effectiveness... - Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopiesHermann Brenner
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Str 20, D 69115 Heidelberg, Germany
Gut 56:1585-9. 2007..To derive age and sex specific estimates of transition rates from advanced adenomas to colorectal cancer by combining data of a nationwide screening colonoscopy registry and national data on colorectal cancer (CRC) incidence... - Tumor M2 pyruvate kinase as a stool marker for colorectal cancer: stability at room temperature and implications for application in the screening settingUlrike Haug
Clin Chem 52:782-4. 2006